Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended March 31, 2026, along with the Auditor''s Report thereon
Awaiting price reaction for this filing.
The company reported strong financial performance for FY26 with consolidated revenue jumping 285% to ₹24,241 lakhs from ₹6,294 lakhs in FY25. Standalone PAT grew 239% to ₹991.65 lakhs while consolidated PAT surged 439% to ₹1,185.37 lakhs. However, the company continues to carry negative other equity (standalone: -₹2,633 lakhs; consolidated: -₹1,997 lakhs). Exceptional gains from sale of PPE contributed significantly — ₹1,571.25 lakhs standalone and ₹1,645.52 lakhs consolidated. The company also raised ₹3,577.80 lakhs through share application money pending allotment. Operating cash flows remained negative at -₹1,701.05 lakhs standalone and -₹1,371.15 lakhs consolidated. Auditors issued an unmodified opinion confirming clean financials.
The company shows turnaround with multi-fold profit growth, but persistent negative equity and negative operating cash flows are red flags. Share capital increase and asset sales suggest potential restructuring underway. Shareholders should monitor the interlocutory application for fresh equity shares.